The EBV-encoded dUTPase activates NF-κB through the TLR2 and MyD88-dependent signaling pathway

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 851-859

  Ariza, Maria Eugenia ^a   Glaser, Ronald ^b,c   Kaumaya, Pravin T P ^b   Jones, Chris ^b   Williams, Marshall V ^b,c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; CD14 ANTIGEN; DUTP PYROPHOSPHATASE; INORGANIC PYROPHOSPHATASE; MYD88 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS INFECTION; CELL CULTURE; CELL LINE; DOSE RESPONSE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTIGENS, CD14; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HERPESVIRUS 4, HUMAN; HUMANS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PYROPHOSPHATASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VIRAL PROTEINS;

EID: 60549097111     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.851     Document Type: Article

References (66)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signaling. Nat. Immunol. 4: 499-511.
2. Beutler, B. 2004. Interferences, questions and possibilities in Toll-like receptor signaling. Nature 430: 257-263.
3. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7: 131-137.
4. Guggemoos, S., D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler. 2008. TLR9 contributes to the antiviral immunity during gamma herpesvirus infection. J. Immnunol. 80: 438-443.
5. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101: 1315-1320.
6. Sato, A., M. M. Linehan, and A. Iwasaki. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA 103: 17343-17348.
7. Wang, J. P., E. A. Kurt-Jones, O. S. Shin, M. D. Manchak, M. J. Lewin, and R. W. Finberg. 2005. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J. Virol. 79: 12658-12666.
8. Compton, T., E. A. Kurt-Jones, K. W. Boehme, J. Belko, E. Latz, D. T. Goldenbock, and R. W. Finberg. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77: 4588-4596.
9. Boehme, K. W., M. Guerrero, and T. Compton. 2006. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177: 7094-7102.
10. Szomololanyi-Tsuda, E., X. Liang, R. M. Welsh, E. A. Kurt-Jones, and R. W. Finberg. 2006. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80: 4286-4291.
11. Gaudreault, E., S. Fiola, M. Olivier, and J. Gosselin. 2007. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 81: 8016-8024.
12. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognization of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198: 513-520.
13. Krug, A., G. D. Luker, W. Barchet, D. A. Leib, S. Akira, and M. Colonna. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103: 143-1437.
14. Hochrein, H., B. Schlatter, M. O'Keeffe, C. Wagner, F. Schmitz, M. Schiemann, S. Bauer, and H. Wagner. 2004. Herpes simplex virus-type 1 induces INF-α production via Toll-like receptor 9-dependent and independent pathways. Proc. Natl. Acad. Sci. USA 101: 11416-11421.
15. Delale, T., A. A. Paquin, C. Asselin-Paturel, M. Dalod, G. Brizard, E. E. M. Bates, P. Kastner, S. Chan, S. Akira, A. Vicari, et al. 2005. MyD88-dependent and -independent murine cytomegalovirus sensing for INF-α release and initiation of immune responses in vivo. J. Immunol. 175: 6723- 6732.
16. Rassa, J. C., and S. R. Ross. 2003. Viruses and Toll-like receptors. Microbes Infect. 5: 961-968.
17. Mansur, D. S., E. G. Kroon, M. L. Nogueri, R. M. E. Arantes, S. C. O. Rodrigues, S. Akira, R. T. Gazzinelli, and M. A. Campos. 2005. Lethal encephalitis in myeloid differentiation factor 88-deficent mice infected with herpes simplex virus 1. Am. J. Pathol. 166: 1419-1426.
18. Glaser, R., G. de-The, G. Lenoir, and J. H. C. Ho. 1976. Superinfection of epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 73: 960-963.
19. Glaser, R., C. M. Lang, K. L. Lee, D. E. Schuller, D. Jacobs, and C. McQuattie. 1980. Attempt to infect nonmalignant nasopharyngeal epithelial cells from humans and squirrel monkeys with Epstein-Barr virus. J. Natl. Cancer Inst. 64: 1085-1090.
20. Gosselin, J., J. Menezes, M. D'Addario, J. Hiscott, L. Flamand, G. Lamoureux, and D. Oth. 1991. Epstein-Barr virus inhibits tumor necrosis factor-α transcription in monocytic cells. Eur. J. Clin. Immunol. 21: 203-205.
21. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, and J. Menezes. 1992. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin 6 and tumor necrosis factor-α. J. Clin. Invest. 89: 1849-1856.
22. Savard, M., C. Belanger, M. Tardif, P. Gourde, L. Flamand, and J. Gosselin. 2000. Infection of primary monocytes by Epstein-Barr virus. J. Virol. 74: 2612-2619.
23. Savard, M., and J. Gosselin. 2006. Epstein-Barr virus immunosuppression of innate immunity mediated by phagocytes. Virus Res. 119: 134-145.
24. Masy, E., E. Adriaenssens, C. Montpellier, P. Crepiex, A. Mougel, B. Quatannens, G. Goormachtigh, N. Faumount, F. Meggetto, C. Auriault, H. Groux, and J. Coll. 2002. Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation. J. Virol. 76: 6460-6472.
25. Nakamura, H., D. Iwakiri, Y. Ono, and S. Fujiwara. 1998. Epstein-Barr virus-infected human T cell line with a unique pattern of viral gene expression. Int. J. Cancer 76: 587-594.
26. Yang, L., K. Aozasa, K. Oshimi, and K. Takada. 2004. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 64: 5332-5337.
27. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, I. Stefanescu, D. V. Ablashi, R. C. Gallo, and J. Menezes. 1992. Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infections and co-infections on cytokine synthesis: a comparative study. J. Immunol. 149: 181-187.
28. Tanner, J. E., C. Alfieri, T. A. Chatil, and F. Diaz-Mitoma. 1996. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J. Virol. 70: 570-575.
29. D'Addario, M., A. Ahmad, A. Morgan, and J. Menezes. 2000. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the up-regulation of the TNF-α gene expression in monocytic cells via NF- κB involving PKC, P13-K and tyrosine kinases. J. Mol. Biol. 298: 765-778.
30. D'Addario, M., T. A. Libermann, J. Xu, A. Ahmad, and J. Menezes. 2001. Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-κB and different signaling pathways. J. Mol. Biol. 308: 501-514.
31. Martin, H. J., J. M. Lee, D. Walls, and S. D. Hayward. 2007. Manipulation of the Toll-like receptor 7 signaling pathway by Epstein-Barr virus. J. Virol. 81: 9748-9758.
32. Glaser, R., M. L. Litsky, D. A. Padgett, R. A. Baiocchi, E. V. Yang, M. Chen, P. E. Yeh, K. B. Green-Church, M. A. Caligiuri, and M. V. Williams. 2006. The EBV-encoded dUTPase induces immune dysregulation: implications for the pathophysiology of EBV-associated disease. Virology 346: 205-218.
33. Waldman, W. J., M. V. Williams, Jr., S. Lemeshow, P. Binkley, D. Guttridge, J. K. Kiecolt-Glaser, D. A. Knight, K. J. Ladner, and R. Glaser. 2008. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav. Immun. 22: 215-223.
34. Richards, C. D. 1998. Interleukin-6. In Cytokines. A. Mire-Sluis and R. Thorpe, eds. Academic Press, San Diego, CA, pp. 87-108.
35. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1: 510-514.
36. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
37. O'Garra, A., and P. Vieria. 2007. TH1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7: 425-428.
38. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
39. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
40. Biebak, K., E. Lein, I. M. Klagge, E. Avota, J. Schneider-Wschaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. Ter Meulen, and S. Schneider-Schaulies. 2002. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J. Virol. 76: 8729 - 8736.
41. Cooper, A., G. Tai, O. Lider, and Y. Shaul. 2005. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparin sulfate and involves TLR2. J. Immunol. 175: 3165-3176.
42. Duesberg, U., A. von dem Bussche, C. Kirshning, K. Miyake, T. Sauerbruch, and U. Spengler. 2002. Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)-core protein is mediated by Toll like receptors (TLRs) 2 and 4. Immunol. Lett. 231: 89-95.
43. Dolganiuc, A., S. Oak, K. Kodys, D. T. Golenbock, R. W. Finberg, E. A. Kurt-Jones, and G. Szabo. 2004. Hepatitis C core antigen and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127: 1513-1524.
44. Mansur, D. S., E. G. Kroon, M. L. Nogueria, R. M. E. Arantes, S. C. O. Rodrigues, S. Akira, R. T. Gazzinelli, and M. A. Campos. 2005. Lethal encephalitis in myeloid differentiation factor 88-deficent mice infected with herpes simplex virus 1. Am. J. Pathol. 166: 1419 -1426.
45. Aravalli, R. N., S. Hu, T. N. Rowen, J. M. Palquist, and J. R. Lokensgard. 2005. TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol. 175: 4189 - 4193.
46. Kurt-Jones, E. A., J. Belko, C. Yu, P. E. Newburger, J. Wang, M. Chan, D. M. Knipe, and R. W. Finberg. 2005. The role of Toll-like receptors in herpes simplex infection of neonates. J. Infect. Dis. 191: 746-748.
47. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defense. Nat. Rev. Immunol. 7: 179-190.
48. Shimakage, M., M. Kimura, S. Yanoma, M. Ibe, S. Yokota, G. Tsujino, T. Kozuka, T. Dezawa, S. Tamura, A. Ohshima, M. Yutsudo, and A. Hakura. 1999. Expression of latent and replicative-infective genes of Epstein-Barr virus in macrophage. Arch. Virol. 144: 157-166.
49. Vabulas, R. M., P. Ahmad-Nejad, C. da-Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 275: 31332-31339.
50. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR 4. J. Biol. Chem. 277: 15028-15034.
51. Sharma, V., and L. Zhang. 2001. Interleukin-8 expression in AIDS-associated lymphoma B-cell lines. Biochem. Biophys. Res. Commun. 282: 369 -375.
52. Mori, A., S. Takao, J. Pradutkanchana, S. Kietthubthew, W. Mitarnun, and T. Ishida. 2003. High tumor necrosis factor-α levels in patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma. Leuk. Res. 27: 493-498.
53. Luciani, M. G., A. Stoppacciaro, G. Peri, A. Mantovani, and L. P. Ruco. 1998. The monocyte chemotactic protein (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumors. Mol. Pathol. 51: 273-278.
54. Klein, S. C., D. Kube, H. Abts, V. Diehl, and H. Tesch. 1996. Promotion of IL8, IL10, TNF-α and TNF-β production by EBV infection. Leuk. Res. 20: 633- 636.
55. Fayad, L., M. J. Keating, J. M. Reuben, S. O'Brien, B.-N. Lee, S. Lerner, and R. Kurzrock. 2001. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97: 256-263.
56. Budiani, D. R., S. Hutahaean, S. M. Haryana, M. Soesatyo, and W. Sosroseno. 2002. Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma. J. Microbiol. Immunol. Infect. 35: 265-271.
57. Lai, R., S. O'Brien, T. Maushouri, A. Rogers, H. Kantarjian, M. Keating, and M. Albitar. 2002. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer 95: 1071-1075.
58. Miyazaki, I., R. K. Cheung, and H. M. Dosch. 1993. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178: 439-447.
59. Ablashi, D. V., A. T. Huang, J. S. Pagano, G. R. Pearson, and C. S. Yang. 1990. Epstein-Barr Virus and Human Disease. Humana Press, Clifton, NJ.
60. Petrella, T., N. Yaziji, F. Colin, G. Rifle, F. Morlevat, L. Arnould, P. Fargeot, and O. Depret. 1997. Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. Anticancer Res. 17: 3907-3913.
61. Brousset, P. 2002. Is the Epstein-Barr virus infection relevant in lymphomagenesis? Human Pathol. 33: 143-145.
62. Iwakiri, D., Y. Eizuru, M. Tokunaga, and K. Takada. 2003. Autocrine growth of Epstein-Barr virus positive gastric carcinoma cells mediated by Epstein-Barr virus-encoded small RNA. Cancer Res. 63: 7062-7067.
63. Thompson, M. P., and R. Kurzrock. 2004. Epstein-Barr virus and cancer. Clin. Cancer Res. 10: 803-821.
64. Salek-Ardakani, S., S. A. Lyons, and J. R. Arrand. 2004. Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of INF-α. J. Immunol. 173: 321-331.
65. Tugizov, S., R. Herrera, P. Veluppillai, J. Greenspan, D. Greenspan, and J. M. Palefsky. 2007. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J. Virol. 81: 5484-5496.
66. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.